Follow The Filings

FEED ENvue Medical

ENvue Medical earnings company data as of 7:53 PM ET 8/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 17 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by FEED's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FEED insider trades
  • $641K bought by 1 insider
  • $153K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Christian Michael Glibert Insider
    Sale
    $144K 210,000 shares at $0.6900 100% of stake
    Traded Jun 22 Filed Jun 22
  2. Christian Michael Glibert 10% owner
    Buy
    $641K 240,000 shares at $2.67 New stake
    Traded Jan 14 Filed Feb 11
  3. Bank Of America Corp. 10% owner, +2 joint filers
    Sale
    $8,906 2,918 shares at $3.05 1.2% of stake
    Traded Feb 2 Filed Feb 4

Also filed in the last 12 months, not counted as buying or selling: 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,2.03,5.03,9.01
8-K 5.03,8.01,9.01
10-Q
8-K 5.07
8-K 1.01,9.01
DEF 14A
8-K 5.02,9.01
8-K 3.01,9.01
SCHEDULE 13D/A —
424B3
10-Q
SCHEDULE 13D/A —
10-K
SCHEDULE 13G/A —
SCHEDULE 13D —
SCHEDULE 13G —
8-K 5.02,9.01
8-K 1.01,3.03,5.03,9.01
8-K 5.02,9.01
8-K 5.02,9.01
424B3
8-K 5.03,7.01,9.01
8-K 5.02,5.07,9.01
8-K 7.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.